Thymosin Alpha-1 – 5mg

Thymosin Alpha-1 (Tα1) is a 28 amino acid synthetic peptide derived from thymosin fraction 5 of thymic tissue. One of the most extensively clinically documented immunomodulatory peptides in current research, having achieved pharmaceutical approval in multiple countries under the brand name Zadaxin for hepatitis B, hepatitis C, and immune deficiency applications. iLab Pharma’s formulation supplies 5mg as a lyophilized vial, the same concentration as the Thymosin Alpha-1 component included in CSD’s iLab Pharma Anti Aging Peptide Stack, making this standalone vial the natural individual sourcing option for researchers continuing Thymosin Alpha-1 protocols beyond the stack or requiring single compound immune research without the full multi peptide bundle.

Thymosin Alpha-1’s immune activation mechanism operates through toll like receptor (TLR) signaling and dendritic cell maturation pathways. By activating TLR2 and TLR9 on dendritic cells and other antigen presenting cells, Tα1 enhances antigen presentation, promotes T helper cell differentiation, stimulates natural killer cell activity, and upregulates pro inflammatory cytokine production in a controlled, targeted manner. Producing immune system upregulation rather than the broad suppression associated with most pharmaceutical immunomodulatory agents. This activation profile makes Thymosin Alpha-1 a frequently studied reference compound in research examining innate and adaptive immune system co ordination, vaccine adjuvant activity, and immune reconstitution in immunocompromised research models.

Thymosin Alpha-1’s research profile is distinct from other immune focused peptides in CSD’s range. Thymalin is a heterogeneous thymic extract delivering multiple peptide fractions that collectively reconstitute thymic secretion activity, broader in scope but less pharmacologically defined. VIP’s immunomodulatory activity operates through VPAC receptor mediated anti inflammatory cytokine suppression. The opposite directional immune modulation from Tα1’s pro immune activation. LL-37’s innate immune activity centers on antimicrobial membrane disruption and chemokine mediated immune cell recruitment. Thymosin Alpha-1’s defined synthetic sequence, documented TLR mediated activation mechanism, and pharmaceutical approval history position it as the most precisely characterized and clinically validated standalone immune activation peptide in CSD’s immunological research range.

iLab Pharma formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD stocks Thymosin Alpha-1 both as this standalone 5mg lyophilized vial and as a component of the iLab Pharma Anti Aging Peptide Stack. Giving researchers the flexibility to source the compound individually or within a comprehensive longevity and immune research bundle from a single verified Canadian supplier. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Reconstitute with bacteriostatic water prior to use. Store lyophilized peptide at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.

Commonly researched alongside Thymalin and VIP in comparative immunomodulatory peptide studies. Browse CSD’s full peptide range for complete sourcing.